THE shell of
failed fruit and vegetable exporter Sumich Group is being resurrected as a
biotechnology hopeful, joining eight WA
companies loosely representing the sector on the stock market.
► After a month - long rally, shares in Neil Woodford's Patient Capital Trust fell 11 % on the news that
biotechnology company Prothena has
failed a key drugs test, says Gavin Lumsden on Citywire.
But while his fans play up his association with the environmental group, they
fail to mention his much stronger ties to fossil fuel - intensive industries: For over 20 years, he's been a paid spokesman for
companies involved in «mining, energy, forestry, aquaculture,
biotechnology, pharmaceuticals and manufacturing.»